Clinical Proteomics

Papers
(The median citation count of Clinical Proteomics is 3. The table below lists those papers that are above that threshold based on CrossRef citation counts [max. 250 papers]. The publications cover those that have been published in the past four years, i.e., from 2021-08-01 to 2025-08-01.)
ArticleCitations
Comparative proteomic analysis of glomerular proteins in primary and bucillamine-induced membranous nephropathy93
Recent progress in mass spectrometry-based urinary proteomics40
From blood drops to biomarkers: a scoping review of microsampling in mass spectrometry-based proteomics29
Changes of serum IgG glycosylation patterns in rheumatoid arthritis26
Data-independent acquisition mass spectrometry in severe rheumatic heart disease (RHD) identifies a proteomic signature showing ongoing inflammation and effectively classifying RHD cases25
Integrative omics reveals subtle molecular perturbations following ischemic conditioning in a porcine kidney transplant model24
CSF levels of brain-derived proteins correlate with brain ventricular volume in cognitively healthy 70-year-olds24
Correction: Kinome and phosphoproteome reprogramming underlies the aberrant immune responses in critically ill COVID-19 patients23
Quantification of putative ovarian cancer serum protein biomarkers using a multiplexed targeted mass spectrometry assay23
Quantitative proteomics analysis based on data-independent acquisition reveals the effect of Shenling Baizhu powder (SLP) on protein expression in MAFLD rat liver tissue22
The relationship between serum astroglial and neuronal markers and AQP4 and MOG autoantibodies22
Proteome profiling of cutaneous leishmaniasis lesions due to dermotropic Leishmania donovani in Sri Lanka20
Serum proteomics for the identification of biomarkers to flag predilection of COVID19 patients to various organ morbidities20
Proteomic alteration of endometrial tissues during secretion in polycystic ovary syndrome may affect endometrial receptivity19
Optimized sample preparation and data analysis for TMT proteomic analysis of cerebrospinal fluid applied to the identification of Alzheimer’s disease biomarkers19
Proteomic characteristics and diagnostic potential of exhaled breath particles in patients with COVID-1917
Potential biomarker proteins for aspiration pneumonia detected by shotgun proteomics using buccal mucosa samples: a cross-sectional case–control study17
Proteomic profiles screening identified novel exosomal protein biomarkers for diagnosis of lung cancer16
An ALS assembly modulator signature in peripheral blood mononuclear cells: implications for ALS pathophysiology, therapeutics, and diagnostics15
Plasma exosome proteomics reveals upregulation of CILP-1 in concave side of paraspinal muscle in adolescent idiopathic scoliosis15
Mass spectrometry quantifies target engagement for a KRASG12C inhibitor in FFPE tumor tissue15
Quantitative site-specific N-glycosylation analysis reveals IgG glyco-signatures for pancreatic cancer diagnosis14
Alterations in the pH of pancreatic juice are associated with chymotrypsin C inactivation and lithostathine precipitation in chronic pancreatitis patients: a proteomic approach13
Neat plasma proteomics: getting the best out of the worst12
Elevated level of multibranched complex glycan reveals an allergic tolerance status12
Discovery of novel glioma serum biomarkers by proximity extension assay12
Correction: A SISCAPA-based approach for detection of SARS-CoV-2 viral antigens from clinical samples11
Plasma proteomics in pediatric patients with sepsis– hopes and challenges11
Robust optimization of SWATH-MS workflow for human blood serum proteome analysis using a quality by design approach11
Proteomics study of primary and recurrent adamantinomatous craniopharyngiomas10
Longitudinal serum proteomics identifies inflammatory and metabolic pathways in hypertensive nephrosclerosis progression10
Association between cardiovascular disease- and inflammation-related serum biomarkers and poor lung function in elderly9
Phospho-heavy-labeled-spiketide FAIMS stepped-CV DDA (pHASED) provides real-time phosphoproteomics data to aid in cancer drug selection9
Quantitative proteomics analysis in small cell carcinoma of cervix reveals novel therapeutic targets9
Proteomic analyses reveal cystatin c is a promising biomarker for evaluation of systemic lupus erythematosus9
Proteomic insights into the pathophysiology of hypertension-associated albuminuria: Pilot study in a South African cohort9
Glial fibrillary acidic protein, neurofilament light, matrix metalloprotease 3 and fatty acid binding protein 4 as non-invasive brain tumor biomarkers9
Plasma proteomic characterization of colorectal cancer patients with FOLFOX chemotherapy by integrated proteomics technology9
Many kinds of oxidized proteins are present more in the urine of the elderly9
Systematic review of type 1 diabetes biomarkers reveals regulation in circulating proteins related to complement, lipid metabolism, and immune response9
A SISCAPA-based approach for detection of SARS-CoV-2 viral antigens from clinical samples8
Quantitative proteomic analysis of HER2 protein expression in PDAC tumors8
Validation of the novel GLAS algorithm as an aid in the detection of liver fibrosis and cirrhosis based on GP73, LG2m, age, and sex8
The novel biomarkers for assessing clinical benefits of continuous renal replacement therapy in pediatric sepsis: a pilot study8
Characterizing age-related changes in intact mitochondrial proteoforms in murine hearts using quantitative top-down proteomics8
Label-free LC–MS/MS proteomics analyses reveal proteomic changes in oxidative stress and the SOD antioxidant strategy in TM cells8
Decreased histidine-rich glycoprotein and increased complement C4-B protein levels in follicular fluid predict the IVF outcomes of recurrent spontaneous abortion8
Kinome and phosphoproteome reprogramming underlies the aberrant immune responses in critically ill COVID-19 patients8
Recent developments in mass-spectrometry-based targeted proteomics of clinical cancer biomarkers8
Integrating multimodal data to predict the progression of hormone-sensitive prostate cancer8
Integrating functional proteomics and next generation sequencing reveals potential therapeutic targets for Taiwanese breast cancer8
sBioSITe enables sensitive identification of the cell surface proteome through direct enrichment of biotinylated peptides8
ARTN and CCL23 predicted chemosensitivity in acute myeloid leukemia: an Olink® proteomics approach7
Proteomic analysis of plasma exosomes in patients with metastatic colorectal cancer7
SPOT: spatial proteomics through on-site tissue-protein-labeling7
Development of a rapid and specific MALDI-TOF mass spectrometric assay for SARS-CoV-2 detection7
Human tear film protein sampling using soft contact lenses7
Identification of potential molecular targets for the treatment of cluster 1 human pheochromocytoma and paraganglioma via comprehensive proteomic characterization7
Airway fibrin formation cascade in allergic asthma exacerbation: implications for inflammation and remodeling7
Novel plasma protein biomarkers from critically ill sepsis patients7
An LC–MS-based designated comparison method with similar performance to the Lp(a) reference measurement procedure to guide molar Lp(a) standardization6
Closing the gaps in patient management of dyslipidemia: stepping into cardiovascular precision diagnostics with apolipoprotein profiling6
Proteomic analysis identifies subgroups of patients with active systemic lupus erythematosus6
Quantitative proteomic analysis of serum-purified exosomes identifies putative pre-eclampsia-associated biomarkers6
Medwakh smoking induces alterations in salivary proteins and cytokine expression: a clinical exploratory proteomics investigation6
Glial cell proteome using targeted quantitative methods for potential multi-diagnostic biomarkers6
Proteomic profiling of extracellular vesicles derived from human serum for the discovery of biomarkers in Avascular necrosis6
Correction to: A novel non‑invasive method allowing for discovery of pathologically relevant proteins from small airways6
Identification of biomarkers of chronic kidney disease among kidney-derived proteins6
A novel non-invasive method allowing for discovery of pathologically relevant proteins from small airways6
Quantitative proteomics reveals protein dysregulation during T cell activation in multiple sclerosis patients compared to healthy controls6
Spatial top-down proteomics for the functional characterization of human kidney6
Frontiers in plasma proteome profiling platforms: innovations and applications5
Proteomic signature associated with chronic kidney disease (CKD) progression identified by data-independent acquisition mass spectrometry5
Proteome profiling of human placenta reveals developmental stage-dependent alterations in protein signature5
New mechanisms and biomarkers of lymph node metastasis in cervical cancer: reflections from plasma proteomics5
Absolute quantitation of human wild-type DNAI1 protein in lung tissue using a nanoLC-PRM-MS-based targeted proteomics approach coupled with immunoprecipitation5
Redefining serological diagnostics with immunoaffinity proteomics5
Functional and quantitative evaluation of the 20S proteasome in serum and intracellular in145 moroccan patients with hematologic malignancies5
Identification of serum N-glycans signatures in three major gastrointestinal cancers by high-throughput N-glycome profiling5
Proteomic analysis identifies dysregulated proteins and associated molecular pathways in a cohort of gallbladder cancer patients of African ancestry5
Transcriptome profiling and proteomic validation reveals targets of the androgen receptor signaling in the BT-474 breast cancer cell line5
Circulating microvesicles and exosomes in small cell lung cancer by quantitative proteomics5
Mass spectrometry-based proteomics as an emerging tool in clinical laboratories5
Application of urine proteomics in the diagnosis and treatment effectiveness monitoring of early-stage Mycosis Fungoides4
Combination of automated sample preparation and micro-flow LC–MS for high-throughput plasma proteomics4
Exploring the novel duo of Reticulocalbin, and Sideroflexin as future biomarker candidates for Exacerbated Chronic Obstructive Pulmonary Disease4
Neoplastic cell enrichment of tumor tissues using coring and laser microdissection for proteomic and genomic analyses of pancreatic ductal adenocarcinoma4
The dynamic changes and sex differences of 147 immune-related proteins during acute COVID-19 in 580 individuals4
Optimized data-independent acquisition approach for proteomic analysis at single-cell level4
Correction to: Using phosphoproteomics data to understand cellular signaling: a comprehensive guide to bioinformatics resources4
Identification of novel proteomic biomarkers for hypertension: a targeted approach for precision medicine4
Comparative proteomic analysis of glomerular proteins in IgA nephropathy and IgA vasculitis with nephritis4
Validation and update of a multivariable prediction model for the identification and management of patients at risk for hepatocellular carcinoma4
Using established biorepositories for emerging research questions: a feasibility study4
Proteomic analysis of 92 circulating proteins and their effects in cardiometabolic diseases4
Identification of SARS-CoV-2 biomarkers in saliva by transcriptomic and proteomics analysis4
The rapid detection of procalcitonin in septic serum using immunoaffinity MALDI chips4
Proteomic profile and predictive markers of outcome in patients with subarachnoid hemorrhage4
OmicsOne: associate omics data with phenotypes in one-click4
Proteome analysis of CD5-positive diffuse large B cell lymphoma FFPE tissue reveals downregulation of DDX3X, DNAJB1, and B cell receptor signaling pathway proteins including BTK and Immunoglobulins4
Early detection of breast cancer through the diagnosis of Nipple Aspirate Fluid (NAF)3
TMT-based proteomic analysis of radiation lung injury in rats3
Identification of circular RNA BTBD7_hsa_circ_0000563 as a novel biomarker for coronary artery disease and the functional discovery of BTBD7_hsa_circ_0000563 based on peripheral blood mononuclear cell3
Differentiation between descending thoracic aortic diseases using machine learning and plasma proteomic signatures3
Orthogonal proteomics methods warrant the development of Duchenne muscular dystrophy biomarkers3
Correction: The dynamic changes and sex differences of 147 immune-related proteins during acute COVID-19 in 580 individuals3
Investigation on the mechanisms of human sperm DNA damage based on the proteomics analysis by SWATH-MS3
Combined urine proteomics and metabolomics analysis for the diagnosis of pulmonary tuberculosis3
A proteomic profile of the healthy human placenta3
Identification and verification of plasma protein biomarkers that accurately identify an ectopic pregnancy3
Multiplex proteomics identifies inflammation-related plasma biomarkers for aging and cardio-metabolic disorders3
Tailored therapeutic decision of rheumatoid arthritis using proteomic strategies: how to start and when to stop?3
Mass spectrometry-based proteomics in basic and translational research of SARS-CoV-2 coronavirus and its emerging mutants3
Proteomic analysis of low- and high-grade human colon adenocarcinoma tissues and tissue-derived primary cell lines reveals unique biological functions of tumours and new protein biomarker candidates3
Change of histone H3 lysine 14 acetylation stoichiometry in human monocyte derived macrophages as determined by MS-based absolute targeted quantitative proteomic approach: HIV infection and methamphet3
Use of MS-GUIDE for identification of protein biomarkers for risk stratification of patients with prostate cancer3
0.34196901321411